Join MySLAS Social


Scientific Journals

JALA and JBS readers are laboratory science and technology professionals who work primarily in life science R&D.  Together, JALA and JBS address the full spectrum of issues that are mission-critical to this important audience, enabling scientific research teams to gain scientific insights, increase productivity, elevate data quality, reduce lab process cycle times and enable experimentation that otherwise would be impossible.

Both JBS and JALA consider previously unpublished, original research and review manuscripts on an ongoing basis from SLAS members and nonmembers.


Journal of Laboratory Automation

Advancing Translational Laboratory Science and Technology

Editor-in-Chief: Dean Ho, Ph.D., University of California, Los Angeles (USA)
Deputy Editor-in-Chief: Edward Kai-Hua Chow, PhD, University of Singapore (Singapore)

JALA explores ways in which scientists adapt advancements in technology for scientific exploration and experimentation. Six issues are published annually in February, April, June, August, October and December.



Journal of Biomolecular Screening

Advancing the Science of Drug Discovery

Editor-in-Chief: Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA)

  • 2013 Impact Factor: 2.012
  • 2013 Rankings: 37 out of 76 in the Analytical Chemistry category;
    85 out of 165 in the Biotechnology & Applied Microbiology category;
    and 49 out of 78 in the Biochemical Research Methods category.
  • Search for JBS articles in MEDLINE with J Biomol Screen or Journal of Biomolecular Screening.
  • How to access JBS Online (instructions for SLAS members).

JBS reports how scientists use adapted technology to pursue new therapeutics for unmet medical needs, including assay development, identification of chemical probes and target identification and validation in general. Ten issues are published annually in January, February, March, April, June, July, August, September, October and December.


SLAS Journal News and Announcements

  • JBS Special Issue Call for Papers: Screening by RNAi and Precise Genome Editing Technologies. Manuscript proposals still being accepted. Click here for more information.
  • JALA Special Issue Call for Papers:  Advancing Scientific Innovation with Acoustic Drop Ejection. Manuscript proposals due October 31, 2014.  Click here for more information.

  • Nominations are now being accepted for the 2015 JALA Ten.

    Every year, the Journal of Laboratory Automation honors the top 10 technological breakthroughs that made seminal impact toward addressing key biological and medical quandaries. The JALA Ten embraces a spectrum of fields that include but are not limited to laboratory automation, robotics, drug discovery, drug screening, novel therapeutic strategies and delivery technologies, diagnostics, nanotechnology, nanomedicine, microtechnology as it relates to biology and medicine, novel characterization techniques and more. Nominations are due October 1 and are open to SLAS members and nonmembers, and self-nominations are welcome.

    Send your nominations to JALA Editor Edward Kai-Hua Chow ( before October 1, 2014. Please include the following details with your nomination:

    1.      SHORT DESCRIPTION:  A concise and original 100-word description of the work and a representative image (photo or illustration with appropriate reprinting permissions).  If selected, both will be included in a feature story about The JALA Ten that will be published in JALA. 

    2.      MORE INFORMATION:  A 500-word detailed report that explains why the nominated work merits selection to the The JALA Ten.

    3.      CITATION:  Nominations must have been officially published (online publication is acceptable) in a peer-reviewed publication to ensure that its technical merit has been evaluated, and the full citation in ACS style must be provided. 

Congratulations to the SLAS Journal Achievement Award Honorees

Tips for Authors:

The National Institutes of Health Public Access Policy Information for Authors

JALA and JBS open access to their peer reviewed scientific content one year after final (print) publication. JALA and JBS also offer open access options to ensure author compliance with major funding mandates of RCUK, NIH, Wellcome Trust and other agencies. The early open access fee is $3,000. Contact for more information.

Call for Volunteers: Journal Manuscript Reviewers Wanted

JALA and JBS rely on volunteer experts to rigorously review manuscripts prior to publication to ensure scientific excellence. Anyone interested in serving as an SLAS volunteer to assess prospective manuscripts for JALA and/or JBS, may register at JBS SAGEtrack and/or JALA SAGEtrack. Please pay special attention to the keywords (areas of expertise) in your personal profile to ensure manuscripts and reviewers are appropriately matched. For more info about expectations for this volunteer role, please read the JALA & JBS Guidelines for Manuscript Reviewers.

SLAS Member Subscription Information

  • SLAS Combination Memberships (BSS & LAS) allow print subscriptions and full online access to both SLAS journals.
  • Regular members of the Biomolecular Sciences Section (BSS) receive a print subscription and full online access to the Journal of Biomolecular Screening (JBS) only.
  • Emerging Economy, Early Career Professional, Retired and Student members of BSS receive full online access to JBS only.
  • Regular members of the Laboratory Automation Section (LAS) receive a print subscription and full online access to the Journal of Laboratory Automation (JALA) only.
  • Emerging Economy, Early Career Professional, Retired and Student members of LAS receive full online access to JALA only.
  • E-Members do not receive print subscriptions or password-protected access to either journal.

Change of Address

  • SLAS Members: Please make changes to your personal membership profile via the SLAS Member Directory. If you have questions: e-mail; telephone +1.877.990.SLAS (7527) or +1.630.256.SLAS (7527).
  • Nonmembers: Please contact the SAGE Journals Customer Service Department at or +1.800.818.7243.